Healthcare Giant Warns Tariffs Will Add $60–$70M to Its Costs

A major US health company estimates that new import tariffs will raise its operating costs by $60–$70 million this year, reflecting a broader strain across the medical sector. Hospitals, insurers, and suppliers are bracing for higher prices on medical devices, pharmaceuticals, and protective equipment, potentially passing added expenses to patients. President Trump’s “Liberation Day” tariffs target a wide range of goods from China and elsewhere, forcing healthcare entities to scramble for less expensive sources or eat the cost. Despite pleas from industry leaders, the administration appears unmoved, framing tariffs as necessary leverage for fair trade. Observers warn that such unexpected cost surges could lead to shortages or price spikes.